U.S. Auto Stock News

Macy’s, Inc. recently reported first-quarter 2026 results, with revenue of US$4,892 million and net income of US$63 million, and modestly raised its full-year net sales guidance to US$21.5 billion–US$21.75 billion, while also updating its ongoing share repurchase activity. Following these updates, several Wall Street firms upgraded their outlook on Macy’s turnaround efforts, highlighting improving operations even as some insiders sold shares and the company continues to face store closures...

Genuine Parts recently announced plans, following pressure from activist investor Elliott, to split by early 2027 into two independent publicly traded companies focused on Global Automotive and Global Industrial operations. The move aims to unlock value by giving each business a clearer identity and investor base, but raises questions around separation costs, potential dis-synergies, and how the future dividend policy will be structured across the two entities. We will now explore how the...

Understanding DRDGOLD’s recent move DRDGOLD (DRD) recently drew attention after a one day gain of 2.27%, standing out against a period where the stock is down about 21% over the past month and 22% over the past 3 months. See our latest analysis for DRDGOLD. Despite the latest one day share price gain, DRDGOLD’s recent momentum has been fading, with the share price down over the past month and year to date, while the 1 year and multi year total shareholder returns remain strongly positive. If...

Ford Motor (F) is back in focus after enthusiasm around its Ford Energy battery storage unit and the restart of a key aluminum supplier, developments that follow strong earnings and rising earnings estimates. See our latest analysis for Ford Motor. Ford’s recent momentum is clear, with a 30 day share price return of 9.36% and a 90 day share price return of 27.16%. The 1 year total shareholder return of 49.30% reflects how earnings, Ford Energy headlines, and improving aluminum supply are...

Event context and recent stock move Covenant Logistics Group (CVLG) stock has drawn attention after a recent move that left shares at US$45.45, with the price higher over the past week, month and past 3 months. See our latest analysis for Covenant Logistics Group. The recent 1-day share price pullback of 1.88% comes after strong momentum, with a 30-day share price return of 42.25% and a 1-year total shareholder return of 101.74%. This indicates sentiment has strengthened over both short and...

LivaNova PLC recently elected experienced global executive Jette Nygaard-Andersen to its Board of Directors and appointed Anne Liddy as Chief Legal Officer, while long-serving director Dr. Sharon O’Kane stepped down after a decade on the Board. These governance changes bring fresh expertise in medtech, legal and compliance oversight, and executive leadership, potentially influencing how LivaNova manages regulatory complexity and long-term corporate priorities. We’ll now examine how adding...

Core & Main (CNM) is back in focus after first quarter results topped earnings expectations, municipal demand held up against weak residential construction, and management reaffirmed full year guidance while expanding its share repurchase authorization. See our latest analysis for Core & Main. The latest earnings beat and guidance reaffirmation come after a year where the share price has eased, with a year-to-date share price return of down 9.51%. The 3-year total shareholder return of 69.16%...

In recent days, Silgan Holdings Inc. participated in a broad rally across the packaging sector, as investors showed increased interest in rigid packaging suppliers serving food, beverage, and household product markets. Amid this sector-wide momentum, Silgan’s above-average forward dividend yield and record of consistent dividend growth are drawing attention from income-focused and value-oriented investors weighing its risk profile. We’ll now explore how this sector-wide interest, alongside...

Denali Therapeutics (DNLI) stock has been in focus after the company and Biogen halted the Phase 2b LUMA trial of BIIB122 for idiopathic Parkinson’s disease, following missed primary and secondary efficacy endpoints. For investors, attention now shifts to Denali’s planned independent Phase 2a BEACON trial in genetically targeted Parkinson’s patients. This keeps BIIB122 in the pipeline but with a narrower, more focused development path. See our latest analysis for Denali Therapeutics. At a...

Star Bulk Carriers recently drew attention with upbeat analyst expectations for significant year-over-year earnings growth and a Zacks Rank #1 (Strong Buy), alongside an upcoming US$0.50 per-share dividend that went ex-dividend on June 12, 2026. This positive outlook has emerged even as Director Nikolaos Karellis sold 20,000 shares on June 11, 2026, completing a year of exclusively insider selling activity. Next, we’ll examine how the bullish earnings revisions, despite ongoing insider...

In recent months, General Mills has faced weakening volumes across key brands, pressure on its North America Retail and Pet segments, and rising concern about debt and dividend coverage, while appointing Dana McNabb as chief operating officer to address these operational challenges. This combination of softer demand, elevated leverage, and leadership change is prompting investors to reassess how durable General Mills’ margins and payout policies may be. We’ll now examine how the new COO...

In recent days, Seagate Technology Holdings reported surging AI-related demand for its HAMR-based Mozaic drives, raised its long-term annual revenue growth target to at least 20%, and moved to redeem its 3.50% Exchangeable Senior Notes due 2028, tightening its balance sheet after eliminating about US$150.70 million of debt. Multi-year agreements that have nearline capacity almost fully allocated through 2027, combined with very large 12‑month stock gains and insider share sales, highlight...

Recently, OFG Bancorp was highlighted as a top dividend stock after lifting its annualized payout by 16.7% year over year while maintaining a relatively low payout ratio. This recognition underscores how the bank’s combination of consistent dividend growth and expectations for solid earnings this fiscal year is shaping investor interest in its income profile. Next, we’ll examine how OFG Bancorp’s stronger dividend growth narrative fits with its existing outlook for earnings resilience and...

Rocket Lab recently announced it will be added to the Nasdaq-100 Index on June 22, 2026, joining the group of the 100 largest non-financial companies on the Nasdaq exchange and signaling its growing presence in the space and technology sector. This milestone, arriving amid heightened sector attention around SpaceX’s blockbuster IPO, underscores how Rocket Lab has become a core reference point for public-market exposure to the commercial space economy. We’ll now examine how Nasdaq-100...

Context for Korn Ferry’s recent share performance Korn Ferry (KFY) has drawn investor attention after a period of solid share performance, with the stock up about 14% over the past month and about 21% over the past 3 months. This recent move is being weighed against the company’s broader fundamentals, including annual revenue of US$2,859.7m, net income of US$265.3m and a market value of about US$3.8b. See our latest analysis for Korn Ferry. At the latest share price of US$73.22, Korn Ferry’s...

Seadrill (SDRL) has come under pressure as energy stocks reacted to escalating geopolitical tensions in the Middle East, with investors weighing headlines around a potential US Iran deal against the risks of prolonged regional uncertainty. See our latest analysis for Seadrill. That sector wide volatility has pulled Seadrill’s 1 month share price return down 11.6%, although the stock still has a 26.6% share price return year to date and a 51.8% total shareholder return over the past year. This...

Earlier in June 2026, Oscar Health reaffirmed its full-year 2026 guidance and highlighted favorable utilization trends at the Goldman Sachs Global Healthcare Conference, while co-founder Mario Schlosser transitioned from President of Technology and CTO to Co-Founder & Advisor to the CEO to advance its artificial intelligence and digital health efforts. Together with analyst upgrades and insider buying, this combination of leadership evolution and confirmation of operating momentum is...

Those following along with Summit Therapeutics Inc. ( NASDAQ:SMMT ) will no doubt be intrigued by the recent purchase...

Lazard (LAZ) is back in focus after reporting May 2026 figures that showed US$1.4b in net asset management outflows, even as overall assets under management reflected market appreciation and currency headwinds. See our latest analysis for Lazard. The recent AUM outflow news comes on top of a share price that is down 12.10% year to date. However, the 3-year total shareholder return of 56.59% points to much stronger longer term performance and suggests recent momentum has cooled. If Lazard’s...

Recent stock performance and business scale Dominion Energy (D) has drawn fresh attention after a period of positive share performance, with the stock most recently closing at $67.91 and showing gains over the past week, month, past 3 months, year to date, and past year. At a market value of about $58.65b, the company sits among larger regulated utilities. Its operations span electricity generation, transmission, and distribution across key service territories in Virginia, North Carolina, and...

Vontier recently reported that it has reduced its absolute Scope 1 and 2 emissions by 49%, surpassing its original 2030 target and setting a new goal of a 65% reduction by 2030, while also highlighting operational gains and community programs such as a US$25,000 contribution to the NACS Foundation’s Neighborhood Nourish initiative in Raleigh. This combination of accelerated emissions cuts and local food security support sheds light on how Vontier is tying cost efficiency, environmental risk...

If you are wondering whether AbbVie at around US$227.73 is giving you enough value for the risk you are taking, the starting point is to understand how that price stacks up against different ways of estimating what the stock might be worth. Over the short term AbbVie has been relatively steady, with the stock up 0.2% over the past week and 9.2% over the last month. Year to date it is down 0.7%, and over longer periods it has returned 23.1% over 1 year, 82.9% over 3 years and 142.8% over 5...

Texas Instruments (TXN) is back in focus after a sector wide rebound in semiconductor stocks tied to easing interest rate pressure following President Trump’s Iran peace deal announcement and renewed enthusiasm around AI infrastructure spending. See our latest analysis for Texas Instruments. Beyond the latest rebound, Texas Instruments’ share price has delivered a 57.84% 90 day share price return and a 69.63% year to date share price return, while 1 year total shareholder return sits at...

In recent days, Ameren has highlighted a major infrastructure buildout to serve new data centers, backed by energy service agreements covering 2.2 gigawatts of additional demand and supporting its investment plan through 2035. Beyond the size of this expansion, the company now faces material execution and supply chain risks as it works to deliver such a large, multi‑year project pipeline. We’ll now examine how Ameren’s long-term data center-driven infrastructure expansion could reshape its...